1Gottesman I. Schizophrenia genesis: the origins of madness. New York : Henry- Holt & Company Inc, 1991:296.
2Lewis CM, Levinson DF, Wise LH, et al. Genome scan meta- analysis of schizophrenia and bipolar disorder, part Ⅱ: schizophrenia. Am J Hum Genet,2003 ,73 :34-48.
3Straub RE, Weinberger DR. Schizophrenia genes-famine to feast. Biol Psychiaty, 2006,60:81-83.
4Barnett JH, Smoller JW. The genetics of bipolar disorder. Neuroscience,2009,164 : 331-343.
5O'Donovan MC, Craddock N, Norton N, et al. Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet,2008,40:1053-1055.
6Esslinger C, Walter H, Kitsch P, et al. Neural mechanisms of a genome-wide supported psychosis variant. Science,2009,324:605.
7Riley B, Thisehon D, Maher BS, et al. Replication of association between schizophrenia and ZNF804A in the Irish case-control study of schizophrenia sample. Mol Psychiatry,2010,15 : 29-37.
8Wellcome Trust Case Control Consortium. Genome-wide association study of 14 000 cases of seven common diseases and 3000 shared controls. Nature,2007,447 : 661-678.
9Ferreira MA, O'Donovan MC, Meng YA, et al. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet,2008,40 : 1056-1058.
10Kempton M J, Ruberto G, Vassos E, et al. Effects of the CACNA1C risk allele for bipolar disorder on cerebral gray matter volume in healthy individuals. Am J Psychiatry,2009,166:1413- 1414.
10Lambert M, De Marinis T, Pfeil J, et al. Establishing remission and good clinical functioning in schizophrenia: predictors of best outcome with long-term risperidone long acting inject table treatment[J]. Eur Psychiatry, 2010,25(4): 220-229.
